loadpatents
name:-0.057915210723877
name:-0.040515899658203
name:-0.0090329647064209
SHERMAN; Bernard Charles Patent Filings

SHERMAN; Bernard Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHERMAN; Bernard Charles.The latest application filed is for "delayed release deferiprone tablets and methods of using the same".

Company Profile
9.29.48
  • SHERMAN; Bernard Charles - Toronto CA
  • Sherman; Bernard Charles - Willowdale ON
  • Sherman; Bernard Charles - Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20220265559 - SHERMAN; Bernard Charles ;   et al.
2022-08-25
Delayed release deferiprone tablets and methods of using the same
Grant 11,357,731 - Sherman , et al. June 14, 2
2022-06-14
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20210386677 - SHERMAN; Bernard Charles ;   et al.
2021-12-16
Delayed release deferiprone tablets and methods of using the same
Grant 10,940,115 - Sherman , et al. March 9, 2
2021-03-09
Delayed release deferiprone tablets and methods of using the same
Grant 10,940,116 - Sherman , et al. March 9, 2
2021-03-09
Delayed release deferiprone tablets and methods of using the same
Grant 10,780,055 - Sherman , et al. Sept
2020-09-22
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20200268672 - SHERMAN; Bernard Charles ;   et al.
2020-08-27
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20200253945 - Kind Code
2020-08-13
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20200237674 - SHERMAN; Bernard Charles ;   et al.
2020-07-30
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20200188309 - SHERMAN; Bernard Charles ;   et al.
2020-06-18
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20190125682 - SHERMAN; Bernard Charles ;   et al.
2019-05-02
Delayed Release Deferiprone Tablets And Methods Of Using The Same
App 20190117581 - SHERMAN; Bernard Charles ;   et al.
2019-04-25
Diclofenac Dosage Forms
App 20180168933 - Sherman; Bernard Charles
2018-06-21
Meloxicam Dosage Forms
App 20180168932 - Sherman; Bernard Charles
2018-06-21
Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride
App 20170056342 - Sherman; Bernard Charles
2017-03-02
Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride
App 20170056343 - Sherman; Bernard Charles
2017-03-02
Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride
App 20170056341 - Sherman; Bernard Charles
2017-03-02
Stable pharmaceutical formulations comprising lubiprostone
Grant 8,940,790 - Sherman January 27, 2
2015-01-27
Stable Pharmaceutical Formulations Comprising Lubiprostone
App 20120270931 - Sherman; Bernard Charles
2012-10-25
Choline Fenofibrate Delayed Release Compositions
App 20120225946 - Sherman; Bernard Charles
2012-09-06
Clarithromycin Extended-release Tablet
App 20120219625 - Sherman; Bernard Charles
2012-08-30
Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant
App 20110028406 - Sherman; Bernard Charles
2011-02-03
Extended-release capsules comprising venlafaxine hydrochloride
App 20090197968 - Sherman; Bernard Charles
2009-08-06
Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
App 20080249317 - Wang; Jianguo ;   et al.
2008-10-09
Tablets comprising entacapone and crospovidone
App 20080139660 - Sherman; Bernard Charles
2008-06-12
Modified release tablets comprising tramadol
App 20070264335 - Sherman; Bernard Charles
2007-11-15
Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
App 20070248665 - Sherman; Bernard Charles
2007-10-25
Controlled-release dosage forms comprising zolpidem or a salt thereof
App 20070231381 - Sherman; Bernard Charles
2007-10-04
Megestrol acetate suspension
App 20070196498 - Sherman; Bernard Charles
2007-08-23
Capsules comprising topiramate
App 20070077294 - Sherman; Bernard Charles
2007-04-05
Itraconazole solution
App 20070021438 - Sherman; Bernard Charles
2007-01-25
Solid compositions comprising gabapentin having improved stability
App 20060165782 - Sherman; Bernard Charles
2006-07-27
Fosinopril sodium tablet formulation
Grant 7,074,429 - Sherman July 11, 2
2006-07-11
Sustained release propafenone hydrochloride capsules
App 20050271718 - Sherman, Bernard Charles
2005-12-08
Dual-spike release formulation for oral drug delivery
App 20050232994 - Sherman, Bernard Charles
2005-10-20
Stable tablets comprising simvastatin
App 20050186270 - Sherman, Bernard Charles
2005-08-25
Clopidogrel bisulfate tablet formulation
Grant 6,914,141 - Sherman July 5, 2
2005-07-05
Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
App 20050129718 - Sherman, Bernard Charles
2005-06-16
Magnesium salt of S-omeprazole
Grant 6,894,066 - Sherman May 17, 2
2005-05-17
Tablets comprising modafinil
App 20040170683 - Sherman, Bernard Charles
2004-09-02
Pharmaceutical compositions comprising moexipril magnesium
Grant 6,767,556 - Sherman July 27, 2
2004-07-27
Pharmaceutical tablets comprising an NSAID and a prostaglandin
Grant 6,740,340 - Sherman May 25, 2
2004-05-25
Benazepril hydrochloride tablet formulations
Grant 6,737,419 - Sherman May 18, 2
2004-05-18
Magnesium omeprazole
Grant 6,713,495 - Sherman March 30, 2
2004-03-30
Extended-release tablets comprising divalproex sodium
App 20040005357 - Sherman, Bernard Charles
2004-01-08
Metformin hydrochloride tablets
Grant 6,667,054 - Sherman December 23, 2
2003-12-23
Magnesium salt of S-omeprazole
App 20030232861 - Sherman, Bernard Charles
2003-12-18
Tablets comprising ciprofloxacin hydrochloride
App 20030229101 - Sherman, Bernard Charles
2003-12-11
Pharmaceutical tablet comprising an NSAID and misoprostol
Grant 6,656,503 - Sherman December 2, 2
2003-12-02
Extended release tablets comprising felodipine
App 20030211149 - Sherman, Bernard Charles
2003-11-13
Stable saccharide-free tablets comprising a salt of quinapril or moexipril
App 20030157165 - Sherman, Bernard Charles
2003-08-21
Metformin Hydrochloride tablets
App 20030104049 - Sherman, Bernard Charles
2003-06-05
Clopidogrel bisulfate tablet formulation
App 20030096837 - Sherman, Bernard Charles
2003-05-22
Liquid for oral administration comprising paroxetine
App 20030078285 - Sherman, Bernard Charles
2003-04-24
Pharmaceutical composition comprising fenofibrate
App 20030031705 - Sherman, Bernard Charles
2003-02-13
Pharmaceutical compositions comprising quinapril magnesium
App 20030027837 - Sherman, Bernard Charles
2003-02-06
Stabilized cefuroxime axetil
App 20030017214 - Sherman, Bernard Charles
2003-01-23
Benazepril Hydrochloride tablet formulations
App 20020183308 - Sherman, Bernard Charles
2002-12-05
Fosinopril sodium tablet formulation
App 20020131999 - Sherman, Bernard Charles
2002-09-19
Pharmaceutical composition comprising fenofibrate
Grant 6,444,225 - Sherman September 3, 2
2002-09-03
Pharmaceutical compositions comprising moexipril magnesium
App 20020037858 - Sherman, Bernard Charles
2002-03-28
Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
App 20010027178 - Sherman, Bernard Charles
2001-10-04
Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
Grant 6,197,335 - Sherman March 6, 2
2001-03-06
Emulsion preconcentrate comprising a cyclosporin, propylene carbonate, and glycerides
Grant 6,159,933 - Sherman December 12, 2
2000-12-12
Extended-release solid oral dosage forms of drugs having low solubility in water
Grant 6,132,772 - Sherman October 17, 2
2000-10-17
Microemulsion preconcentrates comprising cyclosporins
Grant 5,998,365 - Sherman December 7, 1
1999-12-07
Controlled-release pharmaceutical compositions
Grant 5,879,714 - Sherman March 9, 1
1999-03-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed